Literature DB >> 36262400

Development of Esterase-Resistant and Highly Active Ghrelin Analogs via Thiol-Ene Click Chemistry.

Hao-Zheng Li1, Xiao-Xia Shao1, Li-Li Shou1, Ning Li1, Ya-Li Liu1, Zeng-Guang Xu1, Zhan-Yun Guo1.   

Abstract

The orexigenic peptide ghrelin exerts important functions in energy metabolism and has therapeutic potential to treat certain diseases. Native ghrelin carries an essential O-fatty acyl moiety; however, this post-translational modification is susceptible to hydrolysis by certain esterases in circulation, representing a major route of its in vivo inactivation. In the present study, we developed a novel approach to prepare various esterase-resistant ghrelin analogs via photoinduced thiol-ene click chemistry. A recombinant unacylated human ghrelin mutant was reacted with commercially available terminal alkenes; thus, various alkyl moieties were introduced to the side chain of its unique Cys3 residue via a thioether bond. Among 11 S-alkylated ghrelin analogs, analog 11, generated by reacting with 2-methyl-1-octene, not only acquired much higher stability in serum but also retained full activity compared with native human ghrelin. Thus, the present study provided an efficient approach to prepare highly stable and highly active ghrelin analogs with therapeutic potential.
© 2022 American Chemical Society.

Entities:  

Year:  2022        PMID: 36262400      PMCID: PMC9575166          DOI: 10.1021/acsmedchemlett.2c00339

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.632


  33 in total

Review 1.  Des-acyl ghrelin: a metabolically active peptide.

Authors:  Patric J Delhanty; Sebastian J Neggers; Aart J van der Lely
Journal:  Endocr Dev       Date:  2013-04-25

2.  Unusual orthologs shed new light on the binding mechanism of ghrelin to its receptor GHSR1a.

Authors:  Hao-Zheng Li; Xiao-Xia Shao; Li-Li Shou; Ning Li; Ya-Li Liu; Zeng-Guang Xu; Zhan-Yun Guo
Journal:  Arch Biochem Biophys       Date:  2021-04-16       Impact factor: 4.013

Review 3.  Photo-induced radical thiol-ene chemistry: a versatile toolbox for peptide-based drug design.

Authors:  Marzieh Ahangarpour; Iman Kavianinia; Paul W R Harris; Margaret A Brimble
Journal:  Chem Soc Rev       Date:  2021-01-06       Impact factor: 54.564

Review 4.  Ghrelin Signaling: GOAT and GHS-R1a Take a LEAP in Complexity.

Authors:  Alfonso Abizaid; James L Hougland
Journal:  Trends Endocrinol Metab       Date:  2019-10-19       Impact factor: 12.015

Review 5.  Mechanisms in endocrinology: Ghrelin: the differences between acyl- and des-acyl ghrelin.

Authors:  Patric J D Delhanty; Sebastian J Neggers; Aart J van der Lely
Journal:  Eur J Endocrinol       Date:  2012-08-16       Impact factor: 6.664

6.  Structure-activity relationship of ghrelin: pharmacological study of ghrelin peptides.

Authors:  M Matsumoto; H Hosoda; Y Kitajima; N Morozumi; Y Minamitake; S Tanaka; H Matsuo; M Kojima; Y Hayashi; K Kangawa
Journal:  Biochem Biophys Res Commun       Date:  2001-09-14       Impact factor: 3.575

Review 7.  Ghrelin forms in the modulation of energy balance and metabolism.

Authors:  Gianluca Gortan Cappellari; Rocco Barazzoni
Journal:  Eat Weight Disord       Date:  2018-10-24       Impact factor: 4.652

8.  Ghrelin octanoylation mediated by an orphan lipid transferase.

Authors:  Jesus A Gutierrez; Patricia J Solenberg; Douglas R Perkins; Jill A Willency; Michael D Knierman; Zhaoyan Jin; Derrick R Witcher; Shuang Luo; Jude E Onyia; John E Hale
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-28       Impact factor: 11.205

9.  Identifying key residues and key interactions for the binding of LEAP2 to receptor GHSR1a.

Authors:  Hao-Zheng Li; Li-Li Shou; Xiao-Xia Shao; Ya-Li Liu; Zeng-Guang Xu; Zhan-Yun Guo
Journal:  Biochem J       Date:  2020-09-18       Impact factor: 3.857

10.  LEAP2 changes with body mass and food intake in humans and mice.

Authors:  Bharath K Mani; Nancy Puzziferri; Zhenyan He; Juan A Rodriguez; Sherri Osborne-Lawrence; Nathan P Metzger; Navpreet Chhina; Bruce Gaylinn; Michael O Thorner; E Louise Thomas; Jimmy D Bell; Kevin W Williams; Anthony P Goldstone; Jeffrey M Zigman
Journal:  J Clin Invest       Date:  2019-09-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.